BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Blackstone Group

BioCentury | Feb 10, 2023
Management Tracks

Sunder to lead healthcare for Blackstone’s North American PE

Plus: James Park to lead South Korea’s GC Cell and updates from Eurobio, The Jackson Laboratory, Toragen and Adiso
BioCentury | Mar 16, 2022
Deals

March 15 Quick Takes: Blackstone backs Sanofi’s multiple myeloma trial

Plus: Keytruda, Lynparza combo misses, pandemic antiviral initiative launches and updates from Eisai, Biogen and more
BioCentury | May 5, 2021
Management Tracks

Clackson joins Theseus as CEO, plus Calliditas, Cerevel, VistaGen, Escient and Shoreline

Theseus Pharmaceuticals Inc. hired Tim Clackson as president and CEO to succeed Iain Dukes, the co-founder and OrbiMed venture partner who has held the CEO role on an interim basis. Dukes will
BioCentury | Aug 26, 2020
Deals

Aug. 25 Quick Takes: A slew of private financings led by Connect’s $115M series C; plus BMS-Forbius, Takeda deals, Bio-Thera-BeiGene and adds to HKSE, NASDAQ queues

Connect raises $115M C round, eyes pivotal trialsRA Capital’s Derek DiRocco will join the board of Suzhou Connect Biopharmaceuticals Ltd. after the firm led the Chinese biotech’s
Items per page:
1 - 10 of 32